bluebird bio (BLUE) Short Interest Ratio & Short Volume → These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad) Free BLUE Stock Alerts $0.91 -0.01 (-1.08%) (As of 04/25/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media bluebird bio Short Interest DataCurrent Short Volume32,620,000 sharesPrevious Short Volume29,750,000 sharesChange Vs. Previous Month+9.65%Dollar Volume Sold Short$33.60 millionShort Interest Ratio / Days to Cover3.8Last Record DateApril 15, 2024Outstanding Shares109,340,000 sharesPercentage of Shares Shorted29.83%Today's Trading Volume5,710,078 sharesAverage Trading Volume8,794,342 sharesToday's Volume Vs. Average65% Short Selling bluebird bio ? Sign up to receive the latest short interest report for bluebird bio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatBLUE Short Interest Over TimeBLUE Days to Cover Over TimeBLUE Percentage of Float Shorted Over Time Ad Prosper Trading AcademyThese AI trades triggered this morning (545% return)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy bluebird bio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202432,620,000 shares $33.60 million +9.7%N/A3.8 $1.03 3/31/202429,750,000 shares $38.08 million -12.6%N/A3.3 $1.28 3/15/202434,040,000 shares $48.34 million -0.3%N/A3.2 $1.42 2/29/202434,130,000 shares $47.44 million +19.4%N/A2.4 $1.39 2/15/202428,590,000 shares $30.88 million +4.0%N/A2.2 $1.08 1/31/202427,500,000 shares $28.05 million +3.5%N/A2.3 $1.02 Get the Latest News and Ratings for BLUE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for bluebird bio and its competitors with MarketBeat's FREE daily newsletter. 1/15/202426,570,000 shares $39.86 million +10.3%N/A2.4 $1.50 12/31/202324,090,000 shares $33.24 million -5.4%N/A2.4 $1.38 12/15/202325,470,000 shares $83.29 million +16.6%N/A2.8 $3.27 11/30/202321,850,000 shares $83.47 million -2.9%N/A4.7 $3.82 11/15/202322,490,000 shares $73.99 million -8.5%N/A6.4 $3.29 10/31/202324,570,000 shares $72.48 million -0.4%N/A7 $2.95 10/15/202324,670,000 shares $65.62 million +2.3%N/A7 $2.66 9/30/202324,110,000 shares $73.29 million -17.0%N/A5.8 $3.04 9/15/202329,040,000 shares $97.28 million +11.5%N/A7 $3.35 8/31/202326,040,000 shares $98.17 million -1.6%N/A6.3 $3.77 8/15/202326,450,000 shares $95.75 million -8.3%N/A6.2 $3.62 7/31/202328,840,000 shares $113.34 million +13.7%N/A6.6 $3.93 7/15/202325,360,000 shares $76.84 million -21.5%N/A5.8 $3.03 6/30/202332,300,000 shares $106.27 million +6.1%N/A8.1 $3.29 6/15/202330,440,000 shares $121.46 million +23.0%N/A6.8 $3.99 5/31/202324,740,000 shares $82.88 million +5.3%N/A5.2 $3.35 5/15/202323,490,000 shares $96.78 million -0.3%N/A5 $4.12 4/30/202323,550,000 shares $102.44 million -0.8%N/A5.3 $4.35 4/15/202323,740,000 shares $74.07 million -10.3%N/A5.5 $3.12 3/31/202326,450,000 shares $84.11 million +29.0%N/A6.1 $3.18 3/15/202320,510,000 shares $95.37 million +12.2%N/A5.4 $4.65 2/28/202318,280,000 shares $95.06 million +5.5%N/A5.4 $5.20 2/15/202317,320,000 shares $102.88 million +0.2%N/A5.1 $5.94 1/31/202317,290,000 shares $109.79 million -6.3%N/A4.7 $6.35 1/15/202318,450,000 shares $145.57 million +1.2%N/A4.9 $7.89 12/30/202218,240,000 shares $126.22 million -1.1%N/A5.3 $6.92 12/15/202218,450,000 shares $143.54 million +1.0%N/A4.6 $7.78 11/30/202218,270,000 shares $142.32 million -5.2%N/A3.3 $7.79 11/15/202219,270,000 shares $148.38 million -14.5%N/A3.2 $7.70 10/31/202222,540,000 shares $141.33 million +0.5%N/A3.1 $6.27 10/15/202222,440,000 shares $143.39 million -1.2%N/A2.9 $6.39 9/30/202222,710,000 shares $143.75 million +13.0%N/A2.9 $6.33 9/15/202220,100,000 shares $142.51 million +1.8%N/A2.4 $7.09 8/31/202219,740,000 shares $115.28 million +19.9%N/A2 $5.84These AI trades triggered this morning (545% return) (Ad)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy BLUE Short Interest - Frequently Asked Questions What is bluebird bio's current short interest? Short interest is the volume of bluebird bio shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 32,620,000 shares of BLUE short. Learn More on bluebird bio's current short interest. What is a good short interest ratio for bluebird bio? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BLUE shares currently have a short interest ratio of 4.0. Learn More on bluebird bio's short interest ratio. Which institutional investors are shorting bluebird bio? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of bluebird bio: Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is bluebird bio's short interest increasing or decreasing? bluebird bio saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 32,620,000 shares, an increase of 9.6% from the previous total of 29,750,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does bluebird bio's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to bluebird bio: Outlook Therapeutics, Inc. (7.41%), BioAtla, Inc. (11.27%), aTyr Pharma, Inc. (0.56%), Vigil Neuroscience, Inc. (6.18%), Sangamo Therapeutics, Inc. (6.39%), AlloVir, Inc. (5.57%), Curis, Inc. (1.01%), Cardiol Therapeutics Inc. (0.42%), Atara Biotherapeutics, Inc. (9.59%), Omega Therapeutics, Inc. (21.69%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short bluebird bio stock? Short selling BLUE is an investing strategy that aims to generate trading profit from bluebird bio as its price is falling. BLUE shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against bluebird bio? A short squeeze for bluebird bio occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BLUE, which in turn drives the price of the stock up even further. How often is bluebird bio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BLUE, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Outlook Therapeutics Short Interest Data BioAtla Short Interest Data aTyr Pharma Short Interest Data Vigil Neuroscience Short Interest Data Sangamo Therapeutics Short Interest Data AlloVir Short Interest Data Curis Short Interest Data Cardiol Therapeutics Short Interest Data Atara Biotherapeutics Short Interest Data Omega Therapeutics Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BLUE) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe World's First "$20 Trillion Drug?"Behind the MarketsI’m afraid WWIII is a very real possibility Porter & CompanyThe Next Nvidia?InvestorPlaceExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders